First-Line Crizotinib in ALK-Positive Lung Cancer (vol 372, pg 781, 2015)

被引：0
|
作者：
Tural, Deniz
Saadettin, Kilickap
Akan, Ali
Koksoy, Elif B.
机构：
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 2015年 / 372卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：887 / 887
页数：1
相关论文
共 50 条
  • [1] First-Line Crizotinib in ALK-Positive Lung Cancer
    Tural, Deniz
    Kilickap, Saadettin
    NEW ENGLAND JOURNAL OF MEDICINE, 2015, 372 (08): : 781 - 781
  • [2] First-Line Crizotinib in ALK-Positive Lung Cancer REPLY
    Solomon, Benjamin J.
    Mok, Tony
    NEW ENGLAND JOURNAL OF MEDICINE, 2015, 372 (08): : 782 - 782
  • [3] First-Line Crizotinib versus Chemotherapy in ALK-Positive Lung Cancer
    Solomon, Benjamin J.
    Mok, Tony
    Kim, Dong-Wan
    Wu, Yi-Long
    Nakagawa, Kazuhiko
    Mekhail, Tarek
    Felip, Enriqueta
    Cappuzzo, Federico
    Paolini, Jolanda
    Usari, Tiziana
    Iyer, Shrividya
    Reisman, Arlene
    Wilner, Keith D.
    Tursi, Jennifer
    Blackhall, Fiona
    Boyer, M.
    Ganju, V.
    Hughes, B.
    Pavlakis, N.
    Solomon, B.
    Varma, S.
    Berghmans, T.
    Canon, J-L
    Demedts, I.
    Janssens, A.
    Louis, R.
    Pieters, T.
    Schallier, D.
    Surmont, V.
    da Silva, C. Maciel
    Ferreira, C-G Moreira
    Hirsh, V.
    Joy, A.
    Laberge, F.
    Morzycki, W.
    Wierzbicki, R.
    Han, B.
    Liu, X.
    Qin, S.
    Shi, Y.
    Wang, Y.
    Wu, G.
    Wu, Y-L
    Zhou, C.
    Ahvonen, J.
    Barlesi, F.
    Cadranel, J.
    Dansin, E.
    Fayette, J.
    Morere, J-F
    NEW ENGLAND JOURNAL OF MEDICINE, 2014, 371 (23): : 2167 - 2177
  • [4] First-Line Lorlatinib or Crizotinib in Advanced ALK-Positive Lung Cancer
    Shaw, Alice T.
    Bauer, Todd M.
    de Marinis, Filippo
    Felip, Enriqueta
    Goto, Yasushi
    Liu, Geoffrey
    Mazieres, Julien
    Kim, Dong-Wan
    Mok, Tony
    Polli, Anna
    Thurm, Holger
    Calella, Anna M.
    Peltz, Gerson
    Solomon, Benjamin J.
    NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (21): : 2018 - 2029
  • [5] First-Line Crizotinib versus Chemotherapy in ALK-Positive Lung Cancer (vol 371, pg 2167, 2014)
    Solomon, Benjamin J.
    Mok, Tony
    Kim, Dong-Wan
    Wu, Yi-Long
    Nakagawa, Kazuhiko
    Mekhail, Tarek
    Felip, Enriqueta
    Cappuzzo, Federico
    Paolini, Jolanda
    Usari, Tiziana
    Iyer, Shrividya
    Reisman, Arlene
    Wilner, Keith D.
    Tursi, Jennifer
    Blackhall, Fiona
    Boyer, M.
    Ganju, V.
    Hughes, B.
    Pavlakis, N.
    Solomon, B.
    Varma, S.
    Berghmans, T.
    Canon, J-L
    Demedts, I.
    Janssens, A.
    Louis, R.
    Pieters, T.
    Schallier, D.
    Surmont, V.
    da Silva, C. Maciel
    Ferreira, C-G Moreira
    Hirsh, V.
    Joy, A.
    Laberge, F.
    Morzycki, W.
    Wierzbicki, R.
    Han, B.
    Liu, X.
    Qin, S.
    Shi, Y.
    Wang, Y.
    Wu, G.
    Wu, Y-L
    Zhou, C.
    Ahvonen, J.
    Barlesi, F.
    Cadranel, J.
    Dansin, E.
    Fayette, J.
    Morere, J-F
    NEW ENGLAND JOURNAL OF MEDICINE, 2015, 373 (16): : 1582 - 1582
  • [6] Alectinib can replace crizotinib as standard first-line therapy for ALK-positive lung cancer
    Uemura, Takehiro
    Hida, Toyoaki
    ANNALS OF TRANSLATIONAL MEDICINE, 2017, 5 (21)
  • [7] Moving molecularly directed therapies to the first-line in ALK-positive lung cancer: crizotinib is just the beginning
    Klempner, Samuel J.
    Raufi, Alexander
    Ou, Sai-Hong Ignatius
    TRANSLATIONAL LUNG CANCER RESEARCH, 2015, 4 (05) : 649 - 652
  • [8] Crizotinib in ALK-positive lung cancer
    Girard, Nicolas
    LANCET ONCOLOGY, 2012, 13 (10): : 962 - 963
  • [9] Efficacy of crizotinib in first-line treatment of adults with ALK-positive advanced NSCLC
    Zhang, Yi-chen
    Zhou, Qing
    Wu, Yi-Long
    EXPERT OPINION ON PHARMACOTHERAPY, 2016, 17 (12) : 1693 - 1701
  • [10] Intracranial Efficacy of First-Line Crizotinib vs. Chemotherapy in ALK-Positive NSCLC
    Solomon, Benjamin J.
    Cappuzzo, Federico
    Felip, Enriqueta
    Blackhall, Fiona
    Costa, Daniel B.
    Kim, Dong-Wan
    Nakagawa, Kazuhiko
    Wu, Yi-Long
    Mekhail, Tarek
    Paolini, Jolanda
    Tursi, Jennifer
    Usari, Tiziana
    Wilner, Keith D.
    Selaru, Paulina
    Mok, Tony
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S377 - S377
12345